Rakuten Securities’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$243K Sell
5,064
-23,364
-82% -$1M 0.06% 132
2026
Q1
$1.04M Buy
28,428
+16,176
+132% +$766K 0.43% 48
2025
Q4
$623K Buy
12,252
+2,357
+24% +$121K 0.2% 70
2025
Q3
$549K Buy
9,895
+4,725
+91% +$277K 0.2% 67
2025
Q2
$357K Buy
5,170
+2,291
+80% +$156K 0.14% 92
2025
Q1
$200K Buy
2,879
+976
+51% +$80.6K 0.1% 110
2024
Q4
$164K Sell
1,903
-5,601
-75% -$606K 0.06% 121
2024
Q3
$894K Sell
7,504
-238
-3% -$31.7K 0.39% 36
2024
Q2
$1.11M Sell
7,742
-1,284
-14% -$170K 0.47% 30
2024
Q1
$1.16M Buy
9,026
+7,445
+471% +$886K 0.51% 33
2023
Q4
$164K Buy
+1,581
New +$156K 0.13% 100

Other funds holding NVO

Rakuten Securities's NVO Position: Q2 2026 in Review

Rakuten Securities reduced its Novo Nordisk (NVO) stake by 82% in Q2 2026, selling an estimated $1M and leaving 5,064 shares worth $243K. The position accounts for 0.06% of the portfolio, ranked #132.

Rakuten Securities first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.16M in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Rakuten Securities held 5,064 shares of Novo Nordisk worth $243K as of Q2 2026.
  • Rakuten Securities sold 23,364 Novo Nordisk shares in Q2 2026, an estimated $1M.
  • Novo Nordisk made up 0.06% of Rakuten Securities's portfolio in Q2 2026, its #132 holding.
  • Rakuten Securities first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Rakuten Securities's Novo Nordisk position peaked at $1.16M in Q1 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.